To revise the State Plan to expand coverage of store and forward services for the purposes of strengthening and sustaining telehealth as a high-quality, cost effective, and consumer-oriented form of care delivery.
 

To transition the New York State Medicaid non-emergency medical transportation (NEMT) program from an administrative- services only model to a risk-based broker model authorized pursuant to Section 1902(a)(70) of the Social Security Act.

Expands the eligibility rules for its working disability group and modified the premium requirements for the group.

This amendment allows new providers time to obtain their accreditation through an approved accreditation organization thereby increasing access to services.

Updates property values for undue hardship definition and cost effectiveness methodology. Revisions have also been made to the undue hardship criteria by increasing the amount of assets for a qualified undue hardship applicant or related family member.

Removes the federal requirement that practitioners obtain a DATA-Waiver or X-Waiver to prescribe medications, like buprenorphine, to treat patients with opioid use disorder, in accordance with Section 1262 of the Consolidated Appropriations Act, 2023. Providers who have a current license to practice and a Drug Enforcement Administration (DEA) registration authorizing the prescribing of Schedule III drugs may prescribe buprenorphine for the treatment of opioid use disorder or pain management.

Implement temporary policies, which are different from those policies and procedures otherwise applied under your Medicaid state plan, during the period of the Presidential and Secretarial emergency declarations related to the COVID-19 outbreak (or any renewals thereof).

Established coverage and reimbursement for a new Targeted Case Management (TCM) services for Integrated Care for Kids (InCK) in New Haven, CT. The target group is individuals under age 21 and those who are pregnant or up to twelve months postpartum residing in zip coded 0610 and 0611.